Aging Journal News

Aging Journal
Misha Blagosklonny is founder and Editor-in-Chief at Aging and Oncotarget

ABOUT MishaBlagosklonny.com:

Read the latest news about recent and trending scientific papers published by Aging—a rigorously peer-reviewed open-access bi-monthly scientific journal. The Aging Journal focuses on publishing high-quality literature from researchers striving to better understand the intricate nature of the human aging process.

The Aging Journal utilizes an open-access model. This means that research studies, reviews, meta-analyses, and other literature published by Aging, are distributed to read for free online—without barriers that make access more difficult. Since its inception, the mission of Aging—part of the Impact Journals family of journals—has been to make exceptional discoveries rapidly and widely available, eliminate borders between specialties, link different fields of biomedical science, and to foster the application of basic and clinical science.

Impact Journals meets the standards of the Wellcome Trust Publisher Requirements and was included into the Wellcome Trust List of Compliant Publishers.

To learn more, please visit Aging-us.com or follow @AgingJrnl on Twitter and @AgingUS on Facebook.

ABOUT Misha Blagosklonny:

Mikhail (Misha) Blagosklonny, M.D., Ph.D. graduated with his Doctor of Medicine and Doctorate from First Pavlov State Medical University in St. Petersburg, Russia. He then moved to the United States—where he became well-known for his contributions in cancer and aging research. Dr. Blagosklonny has published dozens of experimental and theoretical papers focusing on: 1) the hyperfunction theory of aging and, 2) the selective killing of cancer cells with deregulated cell cycle or drug resistance by exploiting their resistance. The hyperfunction theory has led to the rediscovery of Rapamycin as a well-tolerated anti-aging drug.

To learn more about this venture, visit Rapamycin Press.

Dr. Blagosklonny is also a founder and Editor-in-Chief at Aging and Oncotarget, an Editor-in-Chief at Oncoscience, and an editor at Genes and Cancer. These four journals are part of the Impact Journals family of scientific publications, based out of Orchard Park, NY.

The editorial board assembled at these acclaimed journals includes some of the most focused and diligent researchers in the world of science and medicine. Many are faculty from Ivy League academic universities and senior staff at renowned clinical institutions. Multiple editorial board members at Impact Journals have been honored by elite scientific societies, such as the United States’ National Academy of Sciences, and have won prestigious awards, including the Breakthrough Prize, the Lasker, and the Nobel Prize.

Dr. Blagosklonny is another beacon of excellence serving on the Impact Journals editorial boards.

Read more about Dr. Blagosklonny by clicking here.

Follow Misha Blagosklonny @Blagosklonny.

Comments are closed.

  • Follow Us